Data from multiple sources - Curated by Marshall Pearce - Last updated 06 June 2017

Latest news articles

Added 2 months ago Drug news

Phase III SAHARA study success for SHP 616 Liquid (subcutaneously administered C1 esterase inhibitor [human] Liquid for Injection) to treat Hereditary Angioedema.-Shire plc.

Shire plc announces positive topline Phase III results for the SAHARA study, a global, multi-center, randomized, double-blind, placebo-controlled, partial crossover...

Added 5 months ago Drug news

FDA approves Haegarda (subcutaneous C1-esterase inhibitor) for subcutaneous administration to prevent hereditary angioedema (HAE) attacks in adolescent and adult patients.-CSL Behring

The FDA has approved Haegarda, the first C1 Esterase Inhibitor (Human) for subcutaneous (under the skin) administration to prevent Hereditary...

Added 6 months ago Drug news

Phase III study of SHP 643 (lanadelumab) meets primary endpoint in hereditary angioedema- Shire

Shire announced positive topline Phase III results for the HELP study, a global, multi-center, randomized, double-blind placebo-controlled parallel group trial...

Search all news articles for Immunity disorders

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

+ 7 more

Allergic Rhinitis

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

+ 4 more

Load more


ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

This part of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases...

Added 4 years ago

Search all guidelines for Immunity disorders

Journal articles

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

Rituximab, a monoclonal antibody that targets CD20 on B cells, is now central to the treatment of a variety of malignant and autoimmune disorders.

Added 6 months ago

Human immunoglobulin 10 % with recombinant human hyaluronidase: replacement therapy in patients with primary immunodeficiency disorders

Human immunoglobulin is an established replacement therapy for patients with primary immunodeficiency disorders (PIDs). Recombinant human hyaluronidase (rHuPH20) is a...

Added 3 years ago

Risk factors for oral mucositis in children receiving hematopoietic cell transplantation for primary immunodeficiencies: A retrospective study

OM is a frequent complication for patients undergoing HSCT. The aim of this study was to evaluate the possible risk...

Added 4 years ago

Search all journal articles for Immunity disorders